Voluntary nationwide recall: Betaxolol
Oct. 2023Pharmacy Updates
KVK-Tech Inc. is recalling one lot of Betaxolol tablets, USP 10 mg. This drug is used for the treatment of hypertension (high blood pressure).
KVK-Tech Inc. is recalling one lot of this drug (batch number 17853A) as a precautionary measure because a single Oxycodone HCl tablet 5 mg tablet ws found in one batch of the packaging. Betaxolol tablets have a debossed “K” above bisect “13” on one side and plain on the other side, which looks similar to Oxycodone HCL 5 mg tablets. Inadvertent exposure to a controlled substance, such as oxycodone, in specific patient populations is likely to result in significant slowing in breathing, known as respiratory depression, which is a serious health risk.
As of Sept. 29, 2023, there have been no reports of adverse events related to this recall.
Please see the table below to determine if your product has been recalled:
Product name: Betaxolol tablets USP 10 MG (NDC 10702-0013-01)
Lot number: 17853A
Expiry date:06/2027
If you have Betaxolol 10 mg tablets from this lot, you should stop using/return to place of purchase/discard.
To learn more about this recall, you can take one or more of the steps below.
KVK-Tech Inc. is recalling one lot of this drug (batch number 17853A) as a precautionary measure because a single Oxycodone HCl tablet 5 mg tablet ws found in one batch of the packaging. Betaxolol tablets have a debossed “K” above bisect “13” on one side and plain on the other side, which looks similar to Oxycodone HCL 5 mg tablets. Inadvertent exposure to a controlled substance, such as oxycodone, in specific patient populations is likely to result in significant slowing in breathing, known as respiratory depression, which is a serious health risk.
As of Sept. 29, 2023, there have been no reports of adverse events related to this recall.
Please see the table below to determine if your product has been recalled:
Product name: Betaxolol tablets USP 10 MG (NDC 10702-0013-01)
Lot number: 17853A
Expiry date:06/2027
If you have Betaxolol 10 mg tablets from this lot, you should stop using/return to place of purchase/discard.
To learn more about this recall, you can take one or more of the steps below.
- Talk to your doctor or pharmacist.
- Call KVK-Tech Inc. at 215-579-1842 Ext: 6002. TTY users should call 711. Help is available Monday through Friday from 8 a.m. to 6 p.m. EST.
- Visit the FDA website at upmchp.us/betaxolol-drugrecall.
Recent Announcements
Voluntary nationwide recall: True Metrix (Trividia – May)
Trividia Health is recalling all True Metrix Blood Glucose Systems for an issue with the software design of the E-5 Error Code and instructions for the user in the “Messages” section of the Owner’s Booklet/System instructions for use and online labeling and help guides.May 2026Pharmacy Updates
Community Care Behavioral Health is excited to announce this free upcoming web-based training opportunity:
A growing body of U.S. and international research demonstrates that the rapid legalization and commercialization of gambling—including online casinos and mobile sports betting platforms—are associated with significant and escalating gambling related harm. Although Pennsylvania specific prevalence data remain limited, available evidence is increasingly concerning, with gambling disorder linked to alarmingly high rates of suicide, psychiatric comorbidity, and social and financial harm. Drawing on lessons from the tobacco and opioid crises, this presentation will examine how delayed recognition and regulation can amplify population level harm, underscoring the need for earlier screening, prevention, and policy engagement. Participants will gain practical guidance on identifying patients at elevated risk, implementing evidence informed screening and diagnostic strategies, and applying current treatment approaches across the lifespan.May 2026Education/Webinars
Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions
Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.Apr. 2026Education/Webinars